Indoleamine 2,3 Dioxygenase 1 Market Report

Global and Region Indoleamine 2,3 Dioxygenase 1 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：160
  • REPORT CODE：GMM897392
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Indoleamine 2,3 Dioxygenase 1 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Indoleamine 2,3 Dioxygenase 1market, defines the market attractiveness level of Indoleamine 2,3 Dioxygenase 1 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Indoleamine 2,3 Dioxygenase 1 industry, describes the types of Indoleamine 2,3 Dioxygenase 1 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Indoleamine 2,3 Dioxygenase 1 market and the development prospects and opportunities of Indoleamine 2,3 Dioxygenase 1 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Indoleamine 2,3 Dioxygenase 1 market in Chapter 13.

    By Player:

    • Pfizer Inc

    • BirchBioMed Inc

    • Redx Pharma Plc

    • NewLink Genetics Corp

    • Kyowa Hakko Kirin

    • Genentech Inc

    • IO Biotech ApS

    • F Hoffmann-La Roche Ltd

    • Regen BioPharma Inc

    • Bristol-Myers Squibb Company

    • Globavir Biosciences Inc

    • Incyte Corp

    • Netherlands Translational Research Center BV

    • Ensemble Therapeutics Corp

    By Type:

    • BMS-986205

    • Dcellvax

    • Epacadostat

    • F-001287

    • Galanal

    • Others

    By End-User:

    • Aolpecia

    • Cervical Cancer

    • Gastric Cancer

    • Glioma

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Indoleamine 2,3 Dioxygenase 1 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Indoleamine 2,3 Dioxygenase 1 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Indoleamine 2,3 Dioxygenase 1 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Indoleamine 2,3 Dioxygenase 1 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Indoleamine 2,3 Dioxygenase 1 Market Analysis and Outlook to 2022

    • 7.1 Global Indoleamine 2,3 Dioxygenase 1 Consumption (2017-2022)

    • 7.2 United States Indoleamine 2,3 Dioxygenase 1 Consumption (2017-2022)

    • 7.3 Europe Indoleamine 2,3 Dioxygenase 1 Consumption (2017-2022)

    • 7.4 China Indoleamine 2,3 Dioxygenase 1 Consumption (2017-2022)

    • 7.5 Japan Indoleamine 2,3 Dioxygenase 1 Consumption (2017-2022)

    • 7.6 India Indoleamine 2,3 Dioxygenase 1 Consumption (2017-2022)

    • 7.7 South Korea Indoleamine 2,3 Dioxygenase 1 Consumption (2017-2022)

    8 Region and Country-wise Indoleamine 2,3 Dioxygenase 1 Market Analysis and Outlook to 2028

    • 8.1 Global Indoleamine 2,3 Dioxygenase 1 Consumption Forecast (2022-2028)

    • 8.2 United States Indoleamine 2,3 Dioxygenase 1 Consumption Forecast (2022-2028)

    • 8.3 Europe Indoleamine 2,3 Dioxygenase 1 Consumption Forecast (2022-2028)

    • 8.4 China Indoleamine 2,3 Dioxygenase 1 Consumption Forecast (2022-2028)

    • 8.5 Japan Indoleamine 2,3 Dioxygenase 1 Consumption Forecast (2022-2028)

    • 8.6 India Indoleamine 2,3 Dioxygenase 1 Consumption Forecast (2022-2028)

    • 8.7 South Korea Indoleamine 2,3 Dioxygenase 1 Consumption Forecast (2022-2028)

    9 Global Indoleamine 2,3 Dioxygenase 1 Market Outlook by Types and Applications to 2022

    • 9.1 Global Indoleamine 2,3 Dioxygenase 1 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global BMS-986205 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Dcellvax Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Epacadostat Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global F-001287 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Galanal Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Indoleamine 2,3 Dioxygenase 1 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Aolpecia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cervical Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gastric Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Glioma Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Indoleamine 2,3 Dioxygenase 1 Market Outlook by Types and Applications to 2028

    • 10.1 Global Indoleamine 2,3 Dioxygenase 1 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global BMS-986205 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Dcellvax Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Epacadostat Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global F-001287 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Galanal Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Indoleamine 2,3 Dioxygenase 1 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Aolpecia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Glioma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Indoleamine 2,3 Dioxygenase 1 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Indoleamine 2,3 Dioxygenase 1 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Indoleamine 2,3 Dioxygenase 1 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Indoleamine 2,3 Dioxygenase 1 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Indoleamine 2,3 Dioxygenase 1 Market Competitive Analysis

    • 14.1 Pfizer Inc

      • 14.1.1 Pfizer Inc Company Details

      • 14.1.2 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.2 BirchBioMed Inc

      • 14.2.1 BirchBioMed Inc Company Details

      • 14.2.2 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.3 Redx Pharma Plc

      • 14.3.1 Redx Pharma Plc Company Details

      • 14.3.2 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.4 NewLink Genetics Corp

      • 14.4.1 NewLink Genetics Corp Company Details

      • 14.4.2 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.5 Kyowa Hakko Kirin

      • 14.5.1 Kyowa Hakko Kirin Company Details

      • 14.5.2 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.6 Genentech Inc

      • 14.6.1 Genentech Inc Company Details

      • 14.6.2 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.7 IO Biotech ApS

      • 14.7.1 IO Biotech ApS Company Details

      • 14.7.2 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.8 F Hoffmann-La Roche Ltd

      • 14.8.1 F Hoffmann-La Roche Ltd Company Details

      • 14.8.2 F Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 F Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.9 Regen BioPharma Inc

      • 14.9.1 Regen BioPharma Inc Company Details

      • 14.9.2 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.10 Bristol-Myers Squibb Company

      • 14.10.1 Bristol-Myers Squibb Company Company Details

      • 14.10.2 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.11 Globavir Biosciences Inc

      • 14.11.1 Globavir Biosciences Inc Company Details

      • 14.11.2 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.12 Incyte Corp

      • 14.12.1 Incyte Corp Company Details

      • 14.12.2 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.13 Netherlands Translational Research Center BV

      • 14.13.1 Netherlands Translational Research Center BV Company Details

      • 14.13.2 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product and Service

    • 14.14 Ensemble Therapeutics Corp

      • 14.14.1 Ensemble Therapeutics Corp Company Details

      • 14.14.2 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Indoleamine 2,3 Dioxygenase 1

    • Figure Indoleamine 2,3 Dioxygenase 1 Picture

    • Table Global Indoleamine 2,3 Dioxygenase 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Indoleamine 2,3 Dioxygenase 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Indoleamine 2,3 Dioxygenase 1 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Indoleamine 2,3 Dioxygenase 1 Consumption by Country (2017-2022)

    • Figure United States Indoleamine 2,3 Dioxygenase 1 Consumption and Growth Rate (2017-2022)

    • Table Europe Indoleamine 2,3 Dioxygenase 1 Consumption and Growth Rate (2017-2022)

    • Figure China Indoleamine 2,3 Dioxygenase 1 Consumption and Growth Rate (2017-2022)

    • Figure Japan Indoleamine 2,3 Dioxygenase 1 Consumption and Growth Rate (2017-2022)

    • Figure India Indoleamine 2,3 Dioxygenase 1 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Indoleamine 2,3 Dioxygenase 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Indoleamine 2,3 Dioxygenase 1 Consumption Forecast by Country (2022-2028)

    • Figure United States Indoleamine 2,3 Dioxygenase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Indoleamine 2,3 Dioxygenase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Indoleamine 2,3 Dioxygenase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Indoleamine 2,3 Dioxygenase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Indoleamine 2,3 Dioxygenase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Indoleamine 2,3 Dioxygenase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BMS-986205 Consumption and Growth Rate (2017-2022)

    • Figure Global Dcellvax Consumption and Growth Rate (2017-2022)

    • Figure Global Epacadostat Consumption and Growth Rate (2017-2022)

    • Figure Global F-001287 Consumption and Growth Rate (2017-2022)

    • Figure Global Galanal Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Aolpecia Consumption and Growth Rate (2017-2022)

    • Figure Global Cervical Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Gastric Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Glioma Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global BMS-986205 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dcellvax Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Epacadostat Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global F-001287 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Galanal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aolpecia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glioma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Indoleamine 2,3 Dioxygenase 1 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Indoleamine 2,3 Dioxygenase 1 Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table BirchBioMed Inc (Foundation Year, Company Profile and etc.)

    • Table BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table Redx Pharma Plc (Foundation Year, Company Profile and etc.)

    • Table Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table NewLink Genetics Corp (Foundation Year, Company Profile and etc.)

    • Table NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)

    • Table Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table Genentech Inc (Foundation Year, Company Profile and etc.)

    • Table Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table IO Biotech ApS (Foundation Year, Company Profile and etc.)

    • Table IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table Regen BioPharma Inc (Foundation Year, Company Profile and etc.)

    • Table Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table Globavir Biosciences Inc (Foundation Year, Company Profile and etc.)

    • Table Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table Incyte Corp (Foundation Year, Company Profile and etc.)

    • Table Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table Netherlands Translational Research Center BV (Foundation Year, Company Profile and etc.)

    • Table Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product and Service

    • Table Ensemble Therapeutics Corp (Foundation Year, Company Profile and etc.)

    • Table Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US